Gounder, M., Johnson, M., Heist, R. S., Shapiro, G. I., Postel-Vinay, S., Wilson, F. H., Garralda, E., Wulf, G., Almon, C., Nabhan, S., Aguado-Fraile, E., He, P., Romagnoli, M., Hossain, M., Narayanaswamy, R., Sadou-Dubourgnoux, A., Cooper, M., Askoxylakis, V., Burris, H. A., Tabernero, J. (2025). MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial. Nature Communications. https://doi.org/10.1038/s41467-024-55316-5